Circulating T-Cell Receptor Excision Circles at Birth and Risk of Childhood Cancers

Area of Science:

• Immunology
• Pediatric Oncology
• Public Health

Background:

• T-cell receptor excision circles (TRECs) are vital for newborn screening to detect severe combined immunodeficiency (SCID).
• This study explored if lower, but normal, TREC levels at birth correlate with increased childhood cancer susceptibility.
• Investigating TRECs offers insights into early immune system development and its relation to pediatric cancers.

Purpose of the Study:

• To determine the association between newborn T-cell receptor excision circle (TREC) levels and the risk of developing childhood cancers.
• To assess if TREC levels, even within the normal range, can serve as an indicator for compromised immunity related to cancer risk.
• To analyze TREC data from large newborn screening and cancer registry datasets in California and Texas.

Main Methods:

• A case-control study design was employed, linking newborn screening data with cancer registry information.
• The study included a substantial number of childhood cancer cases and matched controls from California and Texas.
• Statistical analyses were performed to compare TREC levels between cancer cases and control groups within each state.

Main Results:

• In California, acute myeloid leukemia cases showed significantly lower TREC levels than controls (p=0.0051).
• In Texas, acute lymphocytic leukemia cases exhibited significantly higher TREC levels compared to controls (p=0.0034).
• These state-specific findings were not replicated in the other state, and no significant differences were observed for other cancer types.

Conclusions:

• No consistent association was found between birth TREC levels and overall childhood cancer risk.
• The complex nature of childhood cancer etiology may explain the lack of clear TREC level differences.
• Further longitudinal studies incorporating additional immune biomarkers are recommended to elucidate the immunologic basis of childhood cancer.